The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not Allowed)
The Catalyst Award in Diabetes, Endocrinology and Metabolic Diseases (Catalyst-DEMD) is designed to complement NIDDK's traditional, investigator-initiated grant programs by supporting individual scientists who propose pioneering and transformational studies in DEMD topic areas. Applications should be focused on major scientific challenges, and have the potential to produce an unusually high impact on diseases and conditions that are central to the mission of NIDDK's Division of Diabetes, Endocrinology and Metabolic Diseases. To be considered responsive to this initiative, the proposed research should reflect new and novel scientific directions that are distinct from concepts and approaches being pursued in the investigator’s research program or elsewhere.
- Letter of Intent Due Date(s): November 3, 2019
- Application Due Date(s): December 3, 2019
RFA-DK-19-014 Expiration Date December 04, 2019
NOTE: Only single PD/PI applications are allowed. Applications with multiple PD(s)/PI(s) will not be accepted.
Awards will be for $500,000 Direct Costs per year, exclusive of subcontract F&A.
The maximum project period is 5 years.